Target Research looks at the new research projects, which have all been assessed through our vigorous peer review system to ensure that we continue to fund only world-class scientific research. The projects focus on Duchenne muscular dystrophy and will investigate several different ways to develop new potential treatments.
We also take a look at biomarkers, and how researchers and clinicians are working to find safe, easy and non-invasive ways to assess muscle damage and monitor disease progression.
Friends of MDUK receive our Campaign newsletter, Target MD, a copy of our annual Impact Report and other benefits – for only £15 a year by Direct Debit. Visit the Friends of MDUK page to find out more and join today!